Aim:
The aim of the present study was to isolate and characterise chemical compounds from Anthocephalus cadamba Miq. bark and evaluate their anticancer activity by in silico, molecular docking and in vitro studies.
Background:
Anthocephalus cadamba is a traditionally used Indian medicinal plant. The anticancer and phytochemical investigations of this plant bark remain unexplored except only with few studies.
Objectives:
The objective of the study was to evaluate antiproliferative activity of extract and fractions against breast cancer and prostate cancer cell lines. Isolation and characterisatoion of active compounds from bio-active guided fractions. Evaluation of anticancer activity of isolated compounds against breast and prostate cancer cell lines. In addition to in silico and molecular docking interactions of isolated compounds with VEGFR2 and PDGFRα target proteins.
Methods:
The compounds were isolated and purified with the help of repeated column chromatography, and spectral techniques 1D, 2D NMR, GC-MS/MS were used to identify and elucidate the structure of compounds. Moreover, prediction of activity spectra for substances, physiochemical properties, bioactivity radar prediction, bioactivity score, natural-product likeness, ADME, and toxicity parameters of isolated compounds (AC-1 to AC-4) was performed through various in-silico databases and servers. To evaluate the docking interaction profile and binding energies of compounds, three docking tools were utilized AutoDock, AutoDock Vina, and iGEMDOCK, against two targets VEGFR2 and PDGFRα. MD simulation was performed through ligand and receptor molecular dynamic server (LARMD).
Results: The study has shown that the A. cadamba bark chloroform fraction demonstrated a significant inhibitory effect against MDA-MB-231, MCF-7 and PC-3 cells in a dose-time dependent manner. The bioassay guided isolation afforded four molecules AC-1 to AC-4 from chloroform fraction. Moreover, the GC-MS/MS profiling identified fourteen new molecules which were not reported earlier from A. cadamba. The in-silico study showed that the isolated compounds (AC-1 to AC-4) obey Lipinski’s rule and had good oral bioavailability. While compound AC-4 had positive bioactivity scores except for kinase inhibitor activity. The ADMET profiling revealed that AC-4 was non-toxic and easily absorbed in the human intestine, and transportable in the blood-brain barrier when compared with AC-1, AC-2, AC-3 and standard drug doxorubicin. Molecular docking and MD simulation assessment also signified AC-4 anticancer activity with dual inhibitory action against the target proteins VEGFR2 and PDGFRα amongst the studied compounds. The in vitro cell viability assay of isolated compounds demonstrated that AC-1 showed IC50 (μg/mL) value of 34.96 ±3.91, 47.76±3.80 69.1±4.96, AC-2; 68.26±4.22, 54.03±5.14, >100, AC-3; 35.34±4.14, 51.5±51.5, 70.8±5.25 and AC-4; 44.2±3.57, 24.2±2.67, 51.2±2.54 for MDA-MB-231, MCF-7 and PC-3 cancer cell lines, respectively and compared with standard drug doxorubicin. Moreover, fluorescence microscopy confirmed the apoptogenic property of compounds. We also found that AC-4 exhibited significant intracellular ROS production in breast cancer cells which induces apoptosis and eventually cell death.
Conclusion:
In conclusion, A. cadamba afforded four pure molecules AC-1 to AC-4 with identification of fourteen new compounds. The entire in-silico studies concluded that the AC-4 compound had better oral bioavailability, bioactivity score, and ADMET profile amongst studied molecules. Molecular docking analysis and MD simulation also supported AC-4 dual inhibitory action against both VEGFR2 and PDGFRα receptors. Moreover, the isolated molecules AC-1, AC-2, AC-3 and AC-4 were found to be active against MDA-MB-231, MCF-7 and PC-3 cancer cells. The molecule AC-4 induces ROS mediated apoptosis in breast cancer cells. The anticancer inhibitory potentiality of AC-4 is directed to its molecular stereochemistry which specifically binds to the target proteins of breast cancer cells with no toxicological effect. Therefore, AC-4 is suggested to be an effective aspirant for the novel drug design and discovery.